ID   BRSK2_HUMAN             Reviewed;         736 AA.
AC   Q8IWQ3; B3KVE9; E9PLM7; O60843; O95099; Q5J5B4; Q6ZMQ4; Q8TB60;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   12-OCT-2022, entry version 188.
DE   RecName: Full=Serine/threonine-protein kinase BRSK2;
DE            EC=2.7.11.1;
DE   AltName: Full=Brain-selective kinase 2;
DE            EC=2.7.11.26;
DE   AltName: Full=Brain-specific serine/threonine-protein kinase 2;
DE            Short=BR serine/threonine-protein kinase 2;
DE   AltName: Full=Serine/threonine-protein kinase 29;
DE   AltName: Full=Serine/threonine-protein kinase SAD-A;
GN   Name=BRSK2; Synonyms=C11orf7, PEN11B, SADA, STK29; ORFNames=HUSSY-12;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RX   PubMed=16630837; DOI=10.1016/j.neuron.2006.03.018;
RA   Inoue E., Mochida S., Takagi H., Higa S., Deguchi-Tawarada M.,
RA   Takao-Rikitsu E., Inoue M., Yao I., Takeuchi K., Kitajima I., Setou M.,
RA   Ohtsuka T., Takai Y.;
RT   "SAD: a presynaptic kinase associated with synaptic vesicles and the active
RT   zone cytomatrix that regulates neurotransmitter release.";
RL   Neuron 50:261-275(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain;
RA   Guo J.H., Yu L.;
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORS 5 AND 6).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 72-736 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11124703;
RX   DOI=10.1002/1097-0061(200101)18:1<69::aid-yea647>3.0.co;2-h;
RA   Stanchi F., Bertocco E., Toppo S., Dioguardi R., Simionati B., Cannata N.,
RA   Zimbello R., Lanfranchi G., Valle G.;
RT   "Characterization of 16 novel human genes showing high similarity to yeast
RT   sequences.";
RL   Yeast 18:69-80(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 454-736 (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 463-736 (ISOFORM 3).
RX   PubMed=9929968; DOI=10.1007/s100380050096;
RA   Miura K., Miyoshi O., Yun K., Inazawa J., Miyamoto T., Hayashi H.,
RA   Masuzaki H., Yoshimura S., Niikawa N., Jinno Y., Ishimaru T.;
RT   "Repeat-directed isolation of a novel gene preferentially expressed from
RT   the maternal allele in human placenta.";
RL   J. Hum. Genet. 44:1-9(1999).
RN   [8]
RP   FUNCTION, ACTIVITY REGULATION, PHOSPHORYLATION AT THR-174, AND MUTAGENESIS
RP   OF THR-174.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A., Boudeau J.,
RA   Hawley S.A., Udd L., Maekelae T.P., Hardie D.G., Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily,
RT   including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [9]
RP   PHOSPHORYLATION AT THR-260, AND MUTAGENESIS OF THR-260.
RX   PubMed=16870137; DOI=10.1016/j.bbrc.2006.06.178;
RA   Guo Z., Tang W., Yuan J., Chen X., Wan B., Gu X., Luo K., Wang Y., Yu L.;
RT   "BRSK2 is activated by cyclic AMP-dependent protein kinase A through
RT   phosphorylation at Thr260.";
RL   Biochem. Biophys. Res. Commun. 347:867-871(2006).
RN   [10]
RP   PHOSPHORYLATION AT THR-174, AND MUTAGENESIS OF THR-174 AND GLY-310.
RX   PubMed=18339622; DOI=10.1074/jbc.m710381200;
RA   Bright N.J., Carling D., Thornton C.;
RT   "Investigating the regulation of brain-specific kinases 1 and 2 by
RT   phosphorylation.";
RL   J. Biol. Chem. 283:14946-14954(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; SER-382 AND SER-393,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-416 (ISOFORM 4), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-382; SER-393; SER-412 AND
RP   THR-509, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION.
RX   PubMed=19958286; DOI=10.1042/bj20091372;
RA   Fogarty S., Hawley S.A., Green K.A., Saner N., Mustard K.J., Hardie D.G.;
RT   "Calmodulin-dependent protein kinase kinase-beta activates AMPK without
RT   forming a stable complex: synergistic effects of Ca2+ and AMP.";
RL   Biochem. J. 426:109-118(2010).
RN   [15]
RP   FUNCTION.
RX   PubMed=20026642; DOI=10.1242/jcs.058230;
RA   Muller M., Lutter D., Puschel A.W.;
RT   "Persistence of the cell-cycle checkpoint kinase Wee1 in SadA- and SadB-
RT   deficient neurons disrupts neuronal polarity.";
RL   J. Cell Sci. 123:286-294(2010).
RN   [16]
RP   INTERACTION WITH COPS5, SUBCELLULAR LOCATION, AND UBIQUITINATION.
RX   PubMed=22609399; DOI=10.1016/j.bbrc.2012.05.045;
RA   Zhou J., Wan B., Li R., Gu X., Zhong Z., Wang Y., Yu L.;
RT   "Jab1 interacts with brain-specific kinase 2 (BRSK2) and promotes its
RT   degradation in the ubiquitin-proteasome pathway.";
RL   Biochem. Biophys. Res. Commun. 422:647-652(2012).
RN   [17]
RP   SUBCELLULAR LOCATION.
RX   PubMed=22713462; DOI=10.1016/j.bbrc.2012.06.046;
RA   Wang Y., Wan B., Li D., Zhou J., Li R., Bai M., Chen F., Yu L.;
RT   "BRSK2 is regulated by ER stress in protein level and involved in ER
RT   stress-induced apoptosis.";
RL   Biochem. Biophys. Res. Commun. 423:813-818(2012).
RN   [18]
RP   FUNCTION, INTERACTION WITH PAK1, AND MUTAGENESIS OF LYS-48; THR-260 AND
RP   THR-443.
RX   PubMed=22669945; DOI=10.1074/jbc.m112.378372;
RA   Nie J., Sun C., Faruque O., Ye G., Li J., Liang Q., Chang Z., Yang W.,
RA   Han X., Shi Y.;
RT   "Synapses of amphids defective (SAD-A) kinase promotes glucose-stimulated
RT   insulin secretion through activation of p21-activated kinase (PAK1) in
RT   pancreatic beta-Cells.";
RL   J. Biol. Chem. 287:26435-26444(2012).
RN   [19]
RP   FUNCTION, CATALYTIC ACTIVITY, TISSUE SPECIFICITY, AND MUTAGENESIS OF LYS-48
RP   AND THR-174.
RX   PubMed=22798068; DOI=10.1074/jbc.m112.375618;
RA   Chen X.Y., Gu X.T., Saiyin H., Wan B., Zhang Y.J., Li J., Wang Y.L.,
RA   Gao R., Wang Y.F., Dong W.P., Najjar S.M., Zhang C.Y., Ding H.F., Liu J.O.,
RA   Yu L.;
RT   "Brain-selective kinase 2 (BRSK2) phosphorylation on PCTAIRE1 negatively
RT   regulates glucose-stimulated insulin secretion in pancreatic beta-cells.";
RL   J. Biol. Chem. 287:30368-30375(2012).
RN   [20]
RP   CATALYTIC ACTIVITY, AND FUNCTION IN MAPT PHOSPHORYLATION.
RX   PubMed=21985311; DOI=10.1111/j.1471-4159.2011.07523.x;
RA   Yoshida H., Goedert M.;
RT   "Phosphorylation of microtubule-associated protein tau by AMPK-related
RT   kinases.";
RL   J. Neurochem. 120:165-176(2012).
RN   [21]
RP   FUNCTION, SUBCELLULAR LOCATION, UBIQUITINATION, INTERACTION WITH FZR1, AND
RP   DOMAIN KEN BOX MOTIF.
RX   PubMed=23029325; DOI=10.1371/journal.pone.0045932;
RA   Li R., Wan B., Zhou J., Wang Y., Luo T., Gu X., Chen F., Yu L.;
RT   "APC/C(Cdh1) targets brain-specific kinase 2 (BRSK2) for degradation via
RT   the ubiquitin-proteasome pathway.";
RL   PLoS ONE 7:E45932-E45932(2012).
CC   -!- FUNCTION: Serine/threonine-protein kinase that plays a key role in
CC       polarization of neurons and axonogenesis, cell cycle progress and
CC       insulin secretion. Phosphorylates CDK16, CDC25C, MAPT/TAU, PAK1 and
CC       WEE1. Following phosphorylation and activation by STK11/LKB1, acts as a
CC       key regulator of polarization of cortical neurons, probably by
CC       mediating phosphorylation of microtubule-associated proteins such as
CC       MAPT/TAU at 'Thr-529' and 'Ser-579'. Also regulates neuron polarization
CC       by mediating phosphorylation of WEE1 at 'Ser-642' in postmitotic
CC       neurons, leading to down-regulate WEE1 activity in polarized neurons.
CC       Plays a role in the regulation of the mitotic cell cycle progress and
CC       the onset of mitosis. Plays a role in the regulation of insulin
CC       secretion in response to elevated glucose levels, probably via
CC       phosphorylation of CDK16 and PAK1. While BRSK2 phosphorylated at Thr-
CC       174 can inhibit insulin secretion (PubMed:22798068), BRSK2
CC       phosphorylated at Thr-260 can promote insulin secretion
CC       (PubMed:22669945). Regulates reorganization of the actin cytoskeleton.
CC       May play a role in the apoptotic response triggered by endoplasmic
CC       reticulum (ER) stress. {ECO:0000269|PubMed:14976552,
CC       ECO:0000269|PubMed:20026642, ECO:0000269|PubMed:21985311,
CC       ECO:0000269|PubMed:22669945, ECO:0000269|PubMed:22798068,
CC       ECO:0000269|PubMed:23029325}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[tau protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [tau protein]; Xref=Rhea:RHEA:12801, Rhea:RHEA-COMP:13701, Rhea:RHEA-
CC         COMP:13702, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.26;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[tau protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[tau protein]; Xref=Rhea:RHEA:53904, Rhea:RHEA-COMP:13703,
CC         Rhea:RHEA-COMP:13704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.26;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on Thr-174 by
CC       STK11/LKB1. {ECO:0000269|PubMed:14976552}.
CC   -!- SUBUNIT: Interacts with FZR1, a regulatory subunit of the APC ubiquitin
CC       ligase complex. Interacts with COPS5. Interacts with PAK1.
CC       {ECO:0000269|PubMed:22609399, ECO:0000269|PubMed:22669945,
CC       ECO:0000269|PubMed:23029325}.
CC   -!- INTERACTION:
CC       Q8IWQ3; Q92905: COPS5; NbExp=6; IntAct=EBI-3232062, EBI-594661;
CC       Q8IWQ3-3; Q9Y4K3: TRAF6; NbExp=3; IntAct=EBI-13085322, EBI-359276;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome. Cytoplasm, perinuclear region. Endoplasmic
CC       reticulum. Note=Detected at centrosomes during mitosis. Localizes to
CC       the endoplasmic reticulum in response to stress caused by tunicamycin.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q8IWQ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IWQ3-2; Sequence=VSP_008154, VSP_008155;
CC       Name=3;
CC         IsoId=Q8IWQ3-3; Sequence=VSP_008156, VSP_008157;
CC       Name=4;
CC         IsoId=Q8IWQ3-4; Sequence=VSP_013945, VSP_008154, VSP_008155;
CC       Name=5;
CC         IsoId=Q8IWQ3-5; Sequence=VSP_022603, VSP_022604;
CC       Name=6;
CC         IsoId=Q8IWQ3-6; Sequence=VSP_055679, VSP_008154, VSP_008155;
CC   -!- TISSUE SPECIFICITY: Detected in pancreas islets (at protein level).
CC       {ECO:0000269|PubMed:22798068}.
CC   -!- DOMAIN: The KEN box motif is required for interaction with FZR1/CDH1
CC       and essential for APC(CDH1)-mediated ubiquitination.
CC       {ECO:0000269|PubMed:23029325}.
CC   -!- PTM: Phosphorylated at Thr-174 by STK11/LKB1 in complex with STE20-
CC       related adapter-alpha (STRADA) pseudo kinase and CAB39. Not
CC       phosphorylated at Thr-174 by CaMKK2. In contrast, it is phosphorylated
CC       and activated by CaMKK1. May be inactivated via dephosphorylation of
CC       Thr-174 by PP2C. Phosphorylated at Thr-260 by PKA. Phosphorylation at
CC       Thr-260 by PKA was not observed in another study (PubMed:18339622), but
CC       this may reflect differences in the experimental approach.
CC       Phosphorylation at Thr-260 seems to play a role in the regulation of
CC       insulin secretion (PubMed:22669945). {ECO:0000269|PubMed:14976552,
CC       ECO:0000269|PubMed:16870137, ECO:0000269|PubMed:18339622,
CC       ECO:0000269|PubMed:19958286, ECO:0000269|PubMed:22669945}.
CC   -!- PTM: Polyubiquitinated by the APC complex in conjunction with FZR1,
CC       leading to its proteasomal degradation. Targeted for proteasomal
CC       degradation by interaction with COPS5. BRSK2 levels change during the
CC       cell cycle. BRSK2 levels are low at the G1/S boundary and gradually
CC       increase as cells progress into G2 phase. BRSK2 levels decrease rapidly
CC       at the end of mitosis. {ECO:0000269|PubMed:22609399,
CC       ECO:0000269|PubMed:23029325}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD09654.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAD09654.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH24291.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY505125; AAS86443.1; -; mRNA.
DR   EMBL; AF533876; AAP97723.1; -; mRNA.
DR   EMBL; AF533877; AAP97724.1; -; mRNA.
DR   EMBL; AF533878; AAP97725.1; -; mRNA.
DR   EMBL; AF533879; AAP97726.1; -; mRNA.
DR   EMBL; AF533880; AAP97727.1; -; mRNA.
DR   EMBL; AY166857; AAN87839.1; -; mRNA.
DR   EMBL; AK122851; BAG53761.1; -; mRNA.
DR   EMBL; AK131534; BAD18671.1; -; mRNA.
DR   EMBL; AC091196; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC136297; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AJ006701; CAA07196.1; -; mRNA.
DR   EMBL; BC024291; AAH24291.1; ALT_INIT; mRNA.
DR   EMBL; AF020089; AAD09654.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS41590.1; -. [Q8IWQ3-3]
DR   CCDS; CCDS58106.1; -. [Q8IWQ3-2]
DR   CCDS; CCDS58107.1; -. [Q8IWQ3-1]
DR   CCDS; CCDS58108.1; -. [Q8IWQ3-5]
DR   CCDS; CCDS60696.1; -. [Q8IWQ3-6]
DR   RefSeq; NP_001243556.1; NM_001256627.1. [Q8IWQ3-1]
DR   RefSeq; NP_001243558.1; NM_001256629.1. [Q8IWQ3-2]
DR   RefSeq; NP_001243559.1; NM_001256630.1. [Q8IWQ3-5]
DR   RefSeq; NP_001269147.1; NM_001282218.1. [Q8IWQ3-6]
DR   RefSeq; NP_003948.2; NM_003957.3. [Q8IWQ3-3]
DR   AlphaFoldDB; Q8IWQ3; -.
DR   SMR; Q8IWQ3; -.
DR   BioGRID; 114491; 19.
DR   IntAct; Q8IWQ3; 8.
DR   STRING; 9606.ENSP00000371614; -.
DR   BindingDB; Q8IWQ3; -.
DR   ChEMBL; CHEMBL4574; -.
DR   DrugCentral; Q8IWQ3; -.
DR   GuidetoPHARMACOLOGY; 1947; -.
DR   iPTMnet; Q8IWQ3; -.
DR   PhosphoSitePlus; Q8IWQ3; -.
DR   BioMuta; BRSK2; -.
DR   DMDM; 116241272; -.
DR   EPD; Q8IWQ3; -.
DR   jPOST; Q8IWQ3; -.
DR   MassIVE; Q8IWQ3; -.
DR   MaxQB; Q8IWQ3; -.
DR   PaxDb; Q8IWQ3; -.
DR   PeptideAtlas; Q8IWQ3; -.
DR   PRIDE; Q8IWQ3; -.
DR   ProteomicsDB; 21843; -.
DR   ProteomicsDB; 70877; -. [Q8IWQ3-1]
DR   ProteomicsDB; 70878; -. [Q8IWQ3-2]
DR   ProteomicsDB; 70879; -. [Q8IWQ3-3]
DR   ProteomicsDB; 70880; -. [Q8IWQ3-4]
DR   ProteomicsDB; 70881; -. [Q8IWQ3-5]
DR   Antibodypedia; 22872; 226 antibodies from 33 providers.
DR   DNASU; 9024; -.
DR   Ensembl; ENST00000308219.13; ENSP00000310697.9; ENSG00000174672.16. [Q8IWQ3-3]
DR   Ensembl; ENST00000382179.5; ENSP00000371614.1; ENSG00000174672.16. [Q8IWQ3-5]
DR   Ensembl; ENST00000526678.5; ENSP00000433370.1; ENSG00000174672.16. [Q8IWQ3-4]
DR   Ensembl; ENST00000528710.5; ENSP00000433235.1; ENSG00000174672.16. [Q8IWQ3-6]
DR   Ensembl; ENST00000528841.6; ENSP00000432000.1; ENSG00000174672.16. [Q8IWQ3-1]
DR   Ensembl; ENST00000529433.5; ENSP00000433684.1; ENSG00000174672.16. [Q8IWQ3-2]
DR   Ensembl; ENST00000531197.5; ENSP00000431152.1; ENSG00000174672.16. [Q8IWQ3-2]
DR   GeneID; 9024; -.
DR   KEGG; hsa:9024; -.
DR   MANE-Select; ENST00000528841.6; ENSP00000432000.1; NM_001256627.2; NP_001243556.1.
DR   UCSC; uc001lti.5; human. [Q8IWQ3-1]
DR   CTD; 9024; -.
DR   DisGeNET; 9024; -.
DR   GeneCards; BRSK2; -.
DR   HGNC; HGNC:11405; BRSK2.
DR   HPA; ENSG00000174672; Group enriched (brain, pancreas).
DR   MalaCards; BRSK2; -.
DR   MIM; 609236; gene.
DR   neXtProt; NX_Q8IWQ3; -.
DR   OpenTargets; ENSG00000174672; -.
DR   Orphanet; 178469; Autosomal dominant non-syndromic intellectual disability.
DR   PharmGKB; PA36212; -.
DR   VEuPathDB; HostDB:ENSG00000174672; -.
DR   eggNOG; KOG0588; Eukaryota.
DR   GeneTree; ENSGT00940000157462; -.
DR   HOGENOM; CLU_000288_156_2_1; -.
DR   InParanoid; Q8IWQ3; -.
DR   OMA; RKFTTEL; -.
DR   OrthoDB; 1127668at2759; -.
DR   PhylomeDB; Q8IWQ3; -.
DR   TreeFam; TF313967; -.
DR   PathwayCommons; Q8IWQ3; -.
DR   SignaLink; Q8IWQ3; -.
DR   SIGNOR; Q8IWQ3; -.
DR   BioGRID-ORCS; 9024; 8 hits in 1101 CRISPR screens.
DR   ChiTaRS; BRSK2; human.
DR   GeneWiki; BRSK2; -.
DR   GenomeRNAi; 9024; -.
DR   Pharos; Q8IWQ3; Tchem.
DR   PRO; PR:Q8IWQ3; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q8IWQ3; protein.
DR   Bgee; ENSG00000174672; Expressed in right hemisphere of cerebellum and 106 other tissues.
DR   ExpressionAtlas; Q8IWQ3; baseline and differential.
DR   Genevisible; Q8IWQ3; HS.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0150034; C:distal axon; ISS:ARUK-UCL.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0051117; F:ATPase binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0060590; F:ATPase regulator activity; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0048156; F:tau protein binding; NAS:ARUK-UCL.
DR   GO; GO:0050321; F:tau-protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IBA:GO_Central.
DR   GO; GO:0036503; P:ERAD pathway; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0030010; P:establishment of cell polarity; ISS:UniProtKB.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:UniProtKB.
DR   GO; GO:0090176; P:microtubule cytoskeleton organization involved in establishment of planar polarity; ISS:ARUK-UCL.
DR   GO; GO:0030182; P:neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043462; P:regulation of ATP-dependent activity; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0050770; P:regulation of axonogenesis; ISS:ARUK-UCL.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:UniProtKB.
DR   GO; GO:0010975; P:regulation of neuron projection development; ISS:ARUK-UCL.
DR   GO; GO:1904152; P:regulation of retrograde protein transport, ER to cytosol; NAS:ParkinsonsUK-UCL.
DR   GO; GO:2000807; P:regulation of synaptic vesicle clustering; TAS:ARUK-UCL.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; ATP-binding; Cell cycle; Cell division;
KW   Cytoplasm; Cytoskeleton; Endoplasmic reticulum; Exocytosis; Kinase;
KW   Magnesium; Metal-binding; Mitosis; Neurogenesis; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation.
FT   CHAIN           1..736
FT                   /note="Serine/threonine-protein kinase BRSK2"
FT                   /id="PRO_0000085670"
FT   DOMAIN          19..270
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          297..339
FT                   /note="UBA"
FT   REGION          345..475
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          493..513
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          681..736
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           603..605
FT                   /note="KEN box"
FT   COMPBIAS        345..384
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        407..428
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        429..469
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        141
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         25..33
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         48
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         174
FT                   /note="Phosphothreonine; by LKB1"
FT                   /evidence="ECO:0000269|PubMed:14976552,
FT                   ECO:0000269|PubMed:18339622"
FT   MOD_RES         260
FT                   /note="Phosphothreonine; by PKA"
FT                   /evidence="ECO:0000269|PubMed:16870137"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZML2"
FT   MOD_RES         367
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         412
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         423
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q69Z98"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q69Z98"
FT   MOD_RES         455
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q69Z98"
FT   MOD_RES         459
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q69Z98"
FT   MOD_RES         463
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q69Z98"
FT   MOD_RES         509
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         512
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q69Z98"
FT   MOD_RES         513
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q69Z98"
FT   MOD_RES         520
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q69Z98"
FT   VAR_SEQ         1..60
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_055679"
FT   VAR_SEQ         1..30
FT                   /note="MTSTGKDGGAQHAQYVGPYRLEKTLGKGQT -> MSPEGHPSRWARPRRPCI
FT                   CPSSLCSPREPRSGPAVGRGGAAHHRVPAGHTPGPQLLQPHLHLPQGQTWLCLQPSPA
FT                   (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_022603"
FT   VAR_SEQ         408
FT                   /note="Q -> QSKAMFSKSLDIAEAHPQFSKED (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16630837"
FT                   /id="VSP_013945"
FT   VAR_SEQ         647..674
FT                   /note="DTTNCMEMMTGRLSKCGSPLSNFFDVIK -> EPPPPAPGLSWGAGLKGQKV
FT                   ATSYESSL (in isoform 2, isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11124703,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16630837,
FT                   ECO:0000303|Ref.2"
FT                   /id="VSP_008154"
FT   VAR_SEQ         663..678
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_022604"
FT   VAR_SEQ         664..668
FT                   /note="SPLSN -> IIPKS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9929968, ECO:0000303|Ref.2"
FT                   /id="VSP_008156"
FT   VAR_SEQ         669..736
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9929968, ECO:0000303|Ref.2"
FT                   /id="VSP_008157"
FT   VAR_SEQ         675..736
FT                   /note="Missing (in isoform 2, isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:11124703,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16630837,
FT                   ECO:0000303|Ref.2"
FT                   /id="VSP_008155"
FT   MUTAGEN         48
FT                   /note="K->M: Loss of catalytic activity. Causes
FT                   disintegration of actin stress fibers."
FT                   /evidence="ECO:0000269|PubMed:22669945,
FT                   ECO:0000269|PubMed:22798068"
FT   MUTAGEN         174
FT                   /note="T->A: Prevents phosphorylation and activation by
FT                   STK11/LKB1 complex."
FT                   /evidence="ECO:0000269|PubMed:14976552,
FT                   ECO:0000269|PubMed:18339622, ECO:0000269|PubMed:22798068"
FT   MUTAGEN         174
FT                   /note="T->E: Constitutively activated."
FT                   /evidence="ECO:0000269|PubMed:14976552,
FT                   ECO:0000269|PubMed:18339622, ECO:0000269|PubMed:22798068"
FT   MUTAGEN         260
FT                   /note="T->A: Decreased phosphorylation. Nearly abolishes
FT                   stimulation of insulin secretion."
FT                   /evidence="ECO:0000269|PubMed:16870137,
FT                   ECO:0000269|PubMed:22669945"
FT   MUTAGEN         310
FT                   /note="G->A: Decreased activation of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:18339622"
FT   MUTAGEN         443
FT                   /note="T->A: Constitutively activated. Promotes formation
FT                   of actin stress fibers."
FT                   /evidence="ECO:0000269|PubMed:22669945"
FT   CONFLICT        251
FT                   /note="I -> S (in Ref. 2;
FT                   AAP97723/AAP97724/AAP97725/AAP97726/AAP97727/AAN87839 and
FT                   5; CAA07196)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        409
FT                   /note="R -> G (in Ref. 3; BAG53761)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q8IWQ3-4:416
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
SQ   SEQUENCE   736 AA;  81633 MW;  D9EBA511149449E6 CRC64;
     MTSTGKDGGA QHAQYVGPYR LEKTLGKGQT GLVKLGVHCV TCQKVAIKIV NREKLSESVL
     MKVEREIAIL KLIEHPHVLK LHDVYENKKY LYLVLEHVSG GELFDYLVKK GRLTPKEARK
     FFRQIISALD FCHSHSICHR DLKPENLLLD EKNNIRIADF GMASLQVGDS LLETSCGSPH
     YACPEVIRGE KYDGRKADVW SCGVILFALL VGALPFDDDN LRQLLEKVKR GVFHMPHFIP
     PDCQSLLRGM IEVDAARRLT LEHIQKHIWY IGGKNEPEPE QPIPRKVQIR SLPSLEDIDP
     DVLDSMHSLG CFRDRNKLLQ DLLSEEENQE KMIYFLLLDR KERYPSQEDE DLPPRNEIDP
     PRKRVDSPML NRHGKRRPER KSMEVLSVTD GGSPVPARRA IEMAQHGQRS RSISGASSGL
     STSPLSSPRV TPHPSPRGSP LPTPKGTPVH TPKESPAGTP NPTPPSSPSV GGVPWRARLN
     SIKNSFLGSP RFHRRKLQVP TPEEMSNLTP ESSPELAKKS WFGNFISLEK EEQIFVVIKD
     KPLSSIKADI VHAFLSIPSL SHSVISQTSF RAEYKATGGP AVFQKPVKFQ VDITYTEGGE
     AQKENGIYSV TFTLLSGPSR RFKRVVETIQ AQLLSTHDPP AAQHLSDTTN CMEMMTGRLS
     KCGSPLSNFF DVIKQLFSDE KNGQAAQAPS TPAKRSAHGP LGDSAAAGPG PGGDAEYPTG
     KDTAKMGPPT ARREQP
//
